Healthcare billionaire Timothy Springer, PhD, a founding investor in Moderna and a professor of biochemistry at Boston-based Harvard Medical School, is about to see nine-digit growth of his net worth thanks to a new acquisition from pharmaceutical company Eli Lilly.